cobaltiprotoporphyrin has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barakat, M; Barakat, N; El-Adl, M; Eldemerdash, R; Gabr, MM; Hussein, AM; Zhran, F | 1 |
| Abraham, NG; Botros, FT; Drummond, G; Goodman, AI; Olszanecki, R; Omura, S; Rezzani, R; Rodella, L; Stec, DE | 1 |
| Hottendorf, GH; Jollow, DJ; Reinhard, MK; Sanders, TW | 1 |
3 other study(ies) available for cobaltiprotoporphyrin and Kidney Diseases
| Article | Year |
|---|---|
Upregulation of heme oxygenase 1 (HO-1) attenuates kidney damage, oxidative stress and inflammatory reaction during renal ischemia/ reperfusion injury.
Topics: Animals; Heme Oxygenase-1; Inflammation; Kidney Diseases; Male; Oxidative Stress; Protoporphyrins; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Up-Regulation | 2018 |
Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway.
Topics: Animals; Apoptosis; Blood Pressure; Blotting, Western; Cell Nucleus; Creatine; Cyclooxygenase 2; DNA Fragmentation; Gene Expression Regulation, Enzymologic; Genetic Vectors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hypertension, Renovascular; Kidney Diseases; Protoporphyrins; Rats; Rats, Sprague-Dawley; Renal Artery; Retroviridae; RNA, Antisense; Signal Transduction; Tyrosine | 2007 |
Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Gentamicins; Kidney Diseases; Liver; Male; Protoporphyrins; Rats; Rats, Sprague-Dawley | 1993 |